The Library
Cost-utility of cancer therapies - the 'cost' of different utility generation strategies
Tools
Meads, D. M., McCabe, C., Hulme, C. T., Edlin, R., Kharroubi, S. A., Browne, C., Ford, H., Dunn, Janet A. and Marshall, A. (2014) Cost-utility of cancer therapies - the 'cost' of different utility generation strategies. In: ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 08 - 12 Nov 2014 . Published in: Value in Health: The Journal of The International Society for Pharmacoeconomic and Outcomes Research, 17 (7). A327. doi:10.1016/j.jval.2014.08.591 ISSN 1098-3015.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1016/j.jval.2014.08.591
Abstract
Objectives: To explore the impact of different utility measurement strategies on the results of a cost-effectiveness analysis, funding decisions, decision uncertainty and value of information. Methods: Data from a UK trial of two cancer therapies (active versus standard care) were analysed using NICE reference case methods. Within-trial, cost-utility analyses were conducted with utility based on a number of strategies: A) Observed EQ-5D; cancer-specific utility based on the EORTC QLQ-C30 B) the EORTC-8D and C) the QLQ_U; Mapping from QLQ-C30 to EQ-5D using an algorithm generated in D) the same cancer patient group and E) a different cancer group. Incremental cost-effectiveness ratios (ICERS) were calculated. Bootstrapped net benefit estimates allowed generation of cost-effectiveness acceptability curves (CEACs) and population expected value of perfect information (EVPI) was calculated using incremental cost scenarios. Results were compared across utility strategies. Results: There were small but important differences observed in the incremental QALYs which ranged from 0.067 (EQ-5D) to 0.036 (EORTC-8D). Large differences were observed in the ICERs generated; for strategies A to E these were: £57,513; £106,264; £102,785; £90,049; £78,885. Using an incremental cost scenario of £3,000 only strategy A yielded an ICER <£30,000. At a QALY willingness to pay threshold (WTPT) of £20,000 there was little decision uncertainty. However, assuming WTPT=£50,000, the probability the active treatment was cost-effective ranged 0.34 (EQ-5D) to 0.025 (EORTC-8D). Using this threshold, the population EVPI for the strategies were: £3,597,844; £120,621; £155,858; £354,094; £805,847. Conclusions: Different utility sources can lead to very different estimates of cost-effectiveness and value of further research and change funding decisions. Estimates of cost-effectiveness based on mapping (even when the algorithm appears to perform well) can differ substantively from those based on observed scores. The lowest ICERs were obtained with the EQ-5D but this may not capture side-effects picked up by the cancer-specific utility measures.
Item Type: | Conference Item (Paper) | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) | ||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | Value in Health: The Journal of The International Society for Pharmacoeconomic and Outcomes Research | ||||
Publisher: | Elsevier Science Inc. | ||||
ISSN: | 1098-3015 | ||||
Official Date: | November 2014 | ||||
Dates: |
|
||||
Volume: | 17 | ||||
Number: | 7 | ||||
Page Range: | A327 | ||||
DOI: | 10.1016/j.jval.2014.08.591 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access | ||||
Description: | QALY-Related Studies |
||||
Conference Paper Type: | Paper | ||||
Title of Event: | ISPOR 17th Annual European Congress | ||||
Type of Event: | Conference | ||||
Location of Event: | Amsterdam, The Netherlands | ||||
Date(s) of Event: | 08 - 12 Nov 2014 |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |